Search
Search
ASRS: 2025
Jordan Graff, MD, FACS
Show Description +
Dr. Graff explores data from the phase 3 Pagoda trial of the port delivery system (PDS) with ranibizumab (Susvimo, Genentech/Roche) for patients with diabetic macular edema, such as how the PDS compares with an optimized standard-of-care injection regimen in the fellow eye.
Posted: 8/06/2025
Jordan Graff, MD, FACS
Dr. Graff explores data from the phase 3 Pagoda trial of the port delivery system (PDS) with ranibizumab (Susvimo, Genentech/Roche) for patients with diabetic macular edema, such as how the PDS compares with an optimized standard-of-care injection regimen in the fellow eye.
Posted: 8/06/2025
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2025.
Please log in to leave a comment.